Our Partners and Collaborations Validating Our Platform

Combination Screening

Combination
Screening

Learn More

CytoSolve’s in silico combination screening demonstrated synergistic joint health benefits of multi-ingredient equine formulations across inflammation, oxidative stress, and cartilage pathways.

Combination
Screening

Learn More

The Natural Vet and CytoSolve® validated Redoxx® and Bug Check™ using computational screening to prove cellular energy and repellent efficacy.

Combination
Screening

Learn More

British American Tobacco and CytoSolve® used computational modeling to analyze how bioactive ingredients affect molecular pathways to promote relaxation and stress-relief.

Combination
Screening

Learn More

Life Extension and CytoSolve® used computational modeling to discover and optimize three plant-based formulations designed to boost human testosterone levels.

Combination
Screening

Learn More

CytoSolve® screened TridoshaT™’s 12-herb combination in silico to characterize synergy across detox, immune, respiratory, and gastrointestinal pathways.

Combination
Screening

Learn More

CytoSolve® screened Pitta-KaphaT™’s four-herb blend in silico to evaluate synergy across detox, digestion, and metabolic regulation pathways.

Combination
Screening

Learn More

CytoSolve® screened Kapha-VataT™’s seven-herb blend in silico to quantify synergistic pathway effects supporting detox, mood balance, anxiety response, and reproductive function.

Combination
Screening

Learn More

CytoSolve® screened Vata-PittaT™ in silico to compare single-herb versus blend effects, identifying coordinated pathway modulation supporting sleep and relaxation.

Combination
Screening

Learn More

CytoSolve® screened KaphaT™ in silico to compare single-herb versus blend effects, identifying coordinated modulation supporting respiration and nasal openness.

Combination
Screening

Learn More

CytoSolve® screened PittaT™ in silico to compare single-herb versus blend effects, identifying coordinated pathway modulation supporting digestive balance and relaxation.

Combination
Screening

Learn More

CytoSolve® screened VataT™ in silico to compare single-herb versus blend effects, identifying coordinated pathway modulation supporting movement and muscle relaxation.

Combination
Screening

Learn More

CytoSolve® screened BreaThe™ in silico to compare single-herb versus blend effects, identifying coordinated pathway modulation supporting respiration and nasal openness.

Combination
Screening

Learn More

CytoSolve screened ImmuniT™ in silico to compare single-herb versus blend effects, identifying coordinated multi-system pathway modulation supporting immune balance.

Combination
Screening

Learn More

TranquiliT™ combination screening used mechanistic modeling to evaluate multi-herb synergy supporting detoxification, relaxation, sleep quality, and Vata–Pitta balance holistic homeostasis.

Combination
Screening

Learn More

Mechanistic combination screening evaluated multi-herb interactions in FeminiT™ supporting detoxification, reproductive wellness, mood regulation, and Kapha–Vata balance through systems-level modeling.

Combination
Screening

Learn More

Mechanistic combination screening evaluated four-herb interactions supporting detoxification digestion metabolic balance and Pitta–Kapha regulation through systems-level in silico modeling framework.

Combination
Screening

Learn More

Computational combination screening assessed five-herb interactions supporting digestion bowel regularity relaxation and Pitta balance through integrated systems-level mechanistic modeling.

Combination
Screening

Learn More

Computational combination screening evaluated eight-herb interactions supporting joint mobility muscle relaxation detox pathways and Vata balance through systems-level mechanistic modeling.

Combination
Screening

Learn More

Combination screening and systematic bioinformatics modeling evaluated K9-701™ ingredients, revealing multi-pathway nutritional support across immune, metabolic, joint, and systemic health domains.

Combination
Screening

Learn More

In silico combination screening identified an optimized D3–K2–magnesium synergy supporting foundational immune function through systems-level computational biology modeling.

Combination
Screening

Learn More

In silico combination screening identified an optimized zinc–copper–quercetin synergy designed to activate immune pathways through systems-level computational biology modeling.

Combination
Screening

Learn More

In silico combination screening identified an optimized multi-compound synergy designed to downregulate biomarkers associated with discomfort and normal swelling.

Combination
Screening

Learn More

CytoSolve® performed combination screening of caffeine and L-arginine by mechanistically modeling their joint impact on nitric oxide signaling to flag risk.

Combination
Screening

Learn More

CytoSolve® supported combination screening by mechanistically evaluating ingredient–ingredient interactions to inform USP’s risk ranking of multi-ingredient dietary supplements.

Combination
Screening

Learn More

CytoSolve® enabled combination screening of bioactive ingredients using a patient-specific ALS Molecular Digital Twin to evaluate biomarker modulation and disease-relevant bioprocess efficacy.

Combination
Screening

Learn More

CytoSolve® partnered with Alnylam to develop a predictive model linking RNAi knockdown to bradykinin-driven outcomes in HAE therapy.

Combination
Screening

Learn More

CytoSolve® used in silico modeling to evaluate and optimize ingredient combinations for aging-related pain relief, accelerating Nu Skin’s product development.

Combination
Screening

Learn More

CytoSolve® used in silico modeling to demonstrate synergy between apigenin and hesperidin, supporting Ramard’s patent claims for joint pain relief formulation.

Combination
Screening

Learn More

CytoSolve® built an integrated lung-congestion model to quantify ClearLungs® multi-botanical synergy across inflammation, mucus regulation, and airway relaxation.

Combination
Screening

Learn More

CytoSolve® integrated validated skin-pathway models to quantify SeaMeal™ ingredient synergy, linking improved coat appearance to barrier synthesis and oxidative reduction.

Combination
Screening

Learn More

CytoSolve® built a mechanistic systems architecture to model low-grade chronic inflammation and predict synergistic phytonutrient effects validated by clinical observations.

Combination
Screening

Learn More

CytoSolve® delivered a modular systems architecture enabling rapid mechanistic discovery of an USFDA-approved drug combination for pancreatic cancer intervention.